Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PIK3CA mutation + ALK fusion
i
Other names:
NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor, PIK3CA, Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, Phosphoinositide-3-kinase, catalytic, alpha polypeptide, Serine/threonine protein kinase PIK3CA, PtdIns-3-kinase subunit P110-alpha, PI3K-alpha, Phosphatidylinositol-4,5-bisphosphat
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
238
;
5290
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
PIK3CA amplification (12)
ALK amplification (3)
PIK3CA amplification (12)
ALK amplification (3)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
PIK3CA mutation + ALK fusion
Non Small Cell Lung Cancer
PIK3CA mutation + ALK fusion
Non Small Cell Lung Cancer
ALK inhibitor
Resistant: C3 – Early Trials
ALK inhibitor
Resistant
:
C3
ALK inhibitor
Resistant: C3 – Early Trials
ALK inhibitor
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.